PCVX logo

Vaxcyte, Inc. (PCVX) Free Cash Flow

Annual FCF:

-$571.79M-$207.12M(-56.80%)
December 31, 2024

Summary

  • As of today, PCVX annual free cash flow is -$571.79 million, with the most recent change of -$207.12 million (-56.80%) on December 31, 2024.
  • During the last 3 years, PCVX annual free cash flow has fallen by -$443.84 million (-346.89%).
  • PCVX annual free cash flow is now -1673.53% below its all-time high of -$32.24 million, reached on December 31, 2018.

Performance

PCVX Free Cash Flow Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherPCVXcash flow metrics

Quarterly FCF:

-$155.35M-$24.43M(-18.66%)
September 30, 2025

Summary

  • As of today, PCVX quarterly free cash flow is -$155.35 million, with the most recent change of -$24.43 million (-18.66%) on September 30, 2025.
  • Over the past year, PCVX quarterly free cash flow has dropped by -$56.56 million (-57.26%).
  • PCVX quarterly free cash flow is now -1602.66% below its all-time high of -$9.12 million, reached on June 30, 2020.

Performance

PCVX Quarterly Free Cash Flow Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherPCVXcash flow metrics

TTM FCF:

-$620.73M-$56.56M(-10.03%)
September 30, 2025

Summary

  • As of today, PCVX TTM free cash flow is -$620.73 million, with the most recent change of -$56.56 million (-10.03%) on September 30, 2025.
  • Over the past year, PCVX TTM free cash flow has dropped by -$4.49 million (-0.73%).
  • PCVX TTM free cash flow is now -6244.29% below its all-time high of -$9.78 million, reached on March 31, 2019.

Performance

PCVX TTM Free Cash Flow Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherPCVXcash flow metrics

Free Cash Flow Formula

FCF = Cash From Operations − CAPEX

PCVX Free Cash Flow Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year-56.8%-57.3%-0.7%
3Y3 Years-346.9%-294.4%-281.9%
5Y5 Years-1082.8%-1087.3%-1076.8%

PCVX Free Cash Flow Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Year-346.9%at low-294.4%+19.5%-281.9%at low
5Y5-Year-1096.6%at low-1252.0%+19.5%-1199.0%at low
All-TimeAll-Time-1673.5%at low-1602.7%+19.5%-6244.3%at low

PCVX Free Cash Flow History

DateAnnualQuarterlyTTM
Sep 2025
-
-$155.35M(-18.7%)
-$620.73M(-10.0%)
Jun 2025
-
-$130.92M(+32.2%)
-$564.16M(+6.0%)
Mar 2025
-
-$193.03M(-36.5%)
-$600.01M(-4.9%)
Dec 2024
-$571.79M(-56.8%)
-$141.43M(-43.2%)
-$571.79M(+7.2%)
Sep 2024
-
-$98.79M(+40.8%)
-$616.24M(-5.8%)
Jun 2024
-
-$166.77M(-1.2%)
-$582.34M(-22.3%)
Mar 2024
-
-$164.80M(+11.3%)
-$476.17M(-30.6%)
Dec 2023
-$364.67M(-106.7%)
-$185.88M(-186.5%)
-$364.67M(-48.7%)
Sep 2023
-
-$64.89M(-7.1%)
-$245.16M(-11.6%)
Jun 2023
-
-$60.60M(-13.7%)
-$219.66M(-10.3%)
Mar 2023
-
-$53.30M(+19.7%)
-$199.12M(-12.9%)
Dec 2022
-$176.44M
-$66.37M(-68.5%)
-$176.44M(-8.5%)
Sep 2022
-
-$39.39M(+1.7%)
-$162.55M(-6.0%)
Jun 2022
-
-$40.06M(-30.8%)
-$153.29M(-6.4%)
DateAnnualQuarterlyTTM
Mar 2022
-
-$30.62M(+41.6%)
-$144.12M(-12.6%)
Dec 2021
-$127.95M(-167.8%)
-$52.48M(-74.1%)
-$127.95M(-47.1%)
Sep 2021
-
-$30.13M(+2.4%)
-$86.96M(-24.4%)
Jun 2021
-
-$30.89M(-113.7%)
-$69.91M(-45.2%)
Mar 2021
-
-$14.45M(-25.8%)
-$48.15M(-0.8%)
Dec 2020
-$47.78M(+1.2%)
-$11.49M(+12.2%)
-$47.78M(+9.4%)
Sep 2020
-
-$13.08M(-43.4%)
-$52.75M(-7.3%)
Jun 2020
-
-$9.12M(+35.2%)
-$49.18M(+8.5%)
Mar 2020
-
-$14.09M(+14.4%)
-$53.74M(-8.7%)
Dec 2019
-$48.34M(-49.9%)
-$16.46M(-72.9%)
-$49.44M(-49.9%)
Sep 2019
-
-$9.52M(+30.4%)
-$32.98M(-40.6%)
Jun 2019
-
-$13.68M(-39.8%)
-$23.46M(-139.8%)
Mar 2019
-
-$9.78M
-$9.78M
Dec 2018
-$32.24M
-
-

FAQ

  • What is Vaxcyte, Inc. annual free cash flow?
  • What is the all-time high annual free cash flow for Vaxcyte, Inc.?
  • What is Vaxcyte, Inc. annual free cash flow year-on-year change?
  • What is Vaxcyte, Inc. quarterly free cash flow?
  • What is the all-time high quarterly free cash flow for Vaxcyte, Inc.?
  • What is Vaxcyte, Inc. quarterly free cash flow year-on-year change?
  • What is Vaxcyte, Inc. TTM free cash flow?
  • What is the all-time high TTM free cash flow for Vaxcyte, Inc.?
  • What is Vaxcyte, Inc. TTM free cash flow year-on-year change?

What is Vaxcyte, Inc. annual free cash flow?

The current annual free cash flow of PCVX is -$571.79M

What is the all-time high annual free cash flow for Vaxcyte, Inc.?

Vaxcyte, Inc. all-time high annual free cash flow is -$32.24M

What is Vaxcyte, Inc. annual free cash flow year-on-year change?

Over the past year, PCVX annual free cash flow has changed by -$207.12M (-56.80%)

What is Vaxcyte, Inc. quarterly free cash flow?

The current quarterly free cash flow of PCVX is -$155.35M

What is the all-time high quarterly free cash flow for Vaxcyte, Inc.?

Vaxcyte, Inc. all-time high quarterly free cash flow is -$9.12M

What is Vaxcyte, Inc. quarterly free cash flow year-on-year change?

Over the past year, PCVX quarterly free cash flow has changed by -$56.56M (-57.26%)

What is Vaxcyte, Inc. TTM free cash flow?

The current TTM free cash flow of PCVX is -$620.73M

What is the all-time high TTM free cash flow for Vaxcyte, Inc.?

Vaxcyte, Inc. all-time high TTM free cash flow is -$9.78M

What is Vaxcyte, Inc. TTM free cash flow year-on-year change?

Over the past year, PCVX TTM free cash flow has changed by -$4.49M (-0.73%)
On this page